[Clinical analysis of 34 cases with sepsis and systemic capillary leak syndrome].

To study the clinical characteristics of sepsis with systemic capillary leak syndrome(SCLS) and to evaluate the therapeutic effect and clinical significance of fluid therapy adjusted timely in these patients. The clinical data of 34 patients with sepsis and SCLS in the Department of Hepatobiliary Surgery ICU of General Hospital of People's Liberation Army General Hospital from July 2014 to January 2016 were retrospectively analyzed.There were 21 males and 13 females, aged from 21 to 74 years, with an average age of 56.3 years.Primary disease as follows: 18 cases with severe acute pancreatitis, 7 postoperative cases of subtotal hepatectomy, 5 postoperative cases of pancreatoduodenectomy, 4 postoperative cases of cholelithiasis.These patients were divided into survival group and death group according to their 28-day survival status.The clinical data including C-reactive protein(CRP), platelets (PLT), brain natriuretic peptide (BNP), the level of arterial blood lactic acid(LAC), oxygenation index(PaO/FiO, OI), net fluid balance(NFB) and norepinephrine dosage(NE) were collected and compared between two groups at three different intervals(day 1-3, day 4-6, day 7-9). The measurement data and numeration data were statistically analyzed with test and χ test respectively to explore the inherent characteristics of the disease evolution and its clinical significance. The survival group (=23)and the death group(=11)had no significant difference in the characteristics of basic clinical characters.The condition of the survival group and the death group were both in progress in 1-3 days period manifested as increased CRP(=-0.473, =0.640) and BNP levels(=0.140, =0.895), decreased PLT counts(=-0.505, =0.620) in the inflammatory response, decreased LAC(=-1.008, =0.320) and OI level (=-2.379, =0.020)in tissue perfusion index, and positive fluid balance(NFB: =0.910, =0.370), required NE(=-0.853, =0.400) to maintain effective perfusion pressure with systemic edema in both groups.There was no significant difference of all these clinical parameters between the two groups.The patients' condition of the survival group reached a plateau phase, whereas all relative indicators of the death group implied significant aggravation and deterioration of systemic infection(CRP: =-3.438, =0.000; PLT: =1.649, =0.110; BNP: =-10.612, =0.000), tissue perfusion (LAC: =-11.305, =0.000; OI: =2.743, =0.010)and tissue edema NFB(=-4.257, =0.000) and NE(=-7.956, =0.000) in 4-6 days period.In the last 7-9 days period the patients' condition of the survival group took a turn for improvement, yet the condition of the death group continued to deteriorate, refractory septic shock developed and multiple organ dysfunction syndrome followed afterwards inevitably(CRP: =-10.036, =0.000; PLT: =6.061, =0.000; BNP: =-10.119, =0.000; LAC: =-24.466, =0.000; OI: =13.443, =0.010; NFB: =-8.345, =0.000; NE: =-7.121, =0.000). The condition of patient with sepsis and SCLS would be improved markedly at the critical turning point around 7-9 days period since the effective systemic treatment began.If the infection does not be significantly constrolled and SCLS still remains in a sustained extravasation period in 7-9 days, the prognosis of these patients may be worse and the mortality may be higher than that of the patients mentioned before.